
Alfumac D 10mg/0.5mg Tablet ER
Marketer
Innovative Pharmaceuticals
Salt Composition
Alfuzosin (10mg) + Dutasteride (0.5mg)
Overview Alfumac D 10mg/0.5mg Tablet ER
Prostaduo XR 10mg/0.5mg extended-release tablets combine two active ingredients with distinct mechanisms to manage benign prostatic hyperplasia (BPH) in adult males. This medication alleviates symptoms like frequent urination and hesitancy. It does not prevent prostate cancer. Prostaduo XR should be taken whole, after the same meal daily; never crush, chew, or break the tablets. Dosage is determined by your physician. Consistent daily use, even when feeling well, is crucial for optimal symptom relief. While symptom improvement may take up to four weeks, regular intake is essential. Report any worsening or lack of improvement after four weeks to your doctor. Common side effects include reduced sex drive, erectile dysfunction, and breast tenderness or enlargement. Contact your physician if these persist or are concerning. Dizziness or drowsiness are also possible, particularly at treatment initiation. Your doctor prescribed this medication because the potential benefits outweigh the risks. Prostaduo XR is contraindicated for women and children. Inform your doctor of any pre-existing conditions, such as low blood pressure, liver, or kidney disease, before starting treatment. Interactions with other medications are possible; disclose all medications to your doctor. Condom use during sexual activity and regular blood pressure monitoring may be recommended. Discuss alcohol consumption with your healthcare provider.
Primary Ingredients of Alfumac D 10mg/0.5mg Tablet ER
The provided text is "undefined," which has no meaning to rephrase. Therefore, no rewritten text can be provided.
Uses of Alfumac D 10mg/0.5mg Tablet ER
Managing benign prostatic enlargement
Major Benefits of Alfumac D 10mg/0.5mg Tablet ER:
Consume Alfumac D 10mg/0.5mg Extended-Release tablets precisely as your physician directs, adhering to both the prescribed dosage and treatment schedule. Ingest the tablets whole; avoid chewing, crushing, or fracturing them. Administer this medication with a meal.
Common Side effects of Alfumac D 10mg/0.5mg Tablet ER:
- Impotence
- Decreased libido
- Ejaculation disorder
- Headache
- Nausea
- Abdominal pain
- Upper respiratory tract infection
- Breast enlargement in male
- Breast tenderness in male
- Dizziness
How to use Alfumac D 10mg/0.5mg Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Alfumac D 10mg/0.5mg Extended-Release tablets should be administered with a meal.
How Alfumac D 10mg/0.5mg Tablet ER works:
Alfuzosin and Dutasteride extended-release tablets (Alfumac D 10mg/0.5mg) offer dual-action relief from benign prostatic hyperplasia symptoms. Alfuzosin, an alpha-adrenergic blocker, eases urination by relaxing prostate and bladder neck muscles. Simultaneously, Dutasteride, a 5-alpha-reductase inhibitor, reduces prostate size by lowering levels of a key growth hormone.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Alfumac D 10mg/0.5mg Extended-Release Tablets is not established as safe. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on Alfumac D 10mg/0.5mg extended-release tablet use in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Alfumac D 10mg/0.5mg Extended-Release tablets with breastfeeding is currently lacking. Seek professional medical advice.
DrivingUNSAFE
Extended-release Alfumac D 10mg/0.5mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Alfumac D 10mg/0.5mg Extended-Release tablets. Dosage modifications for Alfumac D 10mg/0.5mg Extended-Release tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Alfumac D 10mg/0.5mg Extended-Release tablets. Dosage modification may be necessary; physician consultation is advised. Alfumac D 10mg/0.5mg Extended-Release tablets are contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Alfumac D 10mg/0.5mg Tablet ER :
Should you forget to take your Alfumac D 10mg/0.5mg Extended-Release Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Alfumac D 10mg/0.5mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Urological Care |
